A PHASE I EXPANSION STUDY OF PEGARGIMINASE, CISPLATIN AND PEMETREXED IN ARGININOSUCCINATE SYNTHETASE 1-NEGATIVE RECURRENT HIGH GRADE GLIOMAS (HGGS)
Peter A. Hall(Population Health Research Institute), Peter W. Szlosarek(St Bartholomew's Hospital), Sarah Jefferies(Addenbrooke's Hospital), Simon Pacey(Royal Marsden NHS Foundation Trust), Bor-Wen Wu(Polaris (United States)), Matthew Williams(Charing Cross Hospital), Nelofer Syed(Hammersmith Hospital), Fiona Harris(Cambridge University Hospitals NHS Foundation Trust), Timothy Crook(Royal Surrey County Hospital), Stephen Ellis(Barts Health NHS Trust), Richard Shaffer(Bupa Cromwell Hospital), Michael Sheaff(Moorfields Eye Hospital NHS Foundation Trust), Ramsay S. Khadeir(Queen Mary University of London), Xiaoxing Feng(Polaris (United States)), Amanda Johnston(Polaris (United States)), Jane Evanson(Barts Health NHS Trust), Rachel Lewis(St Bartholomew's Hospital), J. A. Thomson, Nick Plowman(Queen Mary University of London), John S. Bomalaski(Polaris (United States))
Cited by 0
Related Papers
The p53 pathway
|The Journal of Pathology|1999|1.3k
Volumetric Modulated Arc Therapy for Delivery of Prostate Radiotherapy: Comparison With Intensity-Modulated Radiotherapy and Three-Dimensional Conformal Radiotherapy
|International Journal of Radiation Oncology*Biology*Physics|2008|532
Volumetric Modulated Arc Therapy Improves Dosimetry and Reduces Treatment Time Compared to Conventional Intensity-Modulated Radiotherapy for Locoregional Radiotherapy of Left-Sided Breast Cancer and Internal Mammary Nodes
|International Journal of Radiation Oncology*Biology*Physics|2009|365
Adding abiraterone or docetaxel to long-term hormone therapy for prostate cancer: directly randomised data from the STAMPEDE multi-arm, multi-stage platform protocol
|Annals of Oncology|2018|252
Epigenetic status of argininosuccinate synthetase and argininosuccinate lyase modulates autophagy and cell death in glioblastoma
|Cell Death and Disease|2013|169